Consumers
Take control of COVID-19 testing for you and your family, in the privacy of your own home. Here, you’ll find everything you need to know about the rapid, easy QuickVue COVID-19 Test from QuidelOrtho. Including where to buy, how to test and interpret results, and how to download our QVueTM companion app.
While our test packaging has changed, rest assured you can have the same confidence in the results.
- Access simple and animated guided instructions
- Share your COVID-19 test results
- Access historical results for you
- Available on Apple iPhones with iOS 13 or higher and Android smartphones with Android 9 or higher
- This test is authorized for non-prescriptive home-use with self-collection for individuals aged 14 and older
- The test is acceptable for children aged 2-13, with the assistance of an adult
- The intended use of this test is for testing individuals within the first 5 days of symptom onset
- All negative results are presumptive; symptomatic individuals with an initial negative test result must be re-tested once between 48 and 72 hours after the first test using either an antigen test or a molecular test for SARS-CoV-2
Each pack contains:
- Printed instructions
- Test strips
- Nasal swabs
- Tube holder (located on the back of the box)
- Photocard
Latest updates
- Department of Health and Human Services press release
- Centers for Medicare & Medicaid Services FAQs
- Department of Labor FAQs
- Medicare coverage for COVID-19
Help stop the spread
Share your test results with public health authorities. Prevent the spread of COVID-19 and support contact-tracing efforts by reporting your results.
QuickVue COVID-19 Test user instructions video
See how easy it is to use the QuickVue COVID-19 Test and generate your results in just 10 minutes.
Watch the video.
Video transcript (English)
The QuickVue COVID-19 Test is fast, simple and designed to be used in the comfort of your home. This easy-to-use test requires a nasal swab sample to determine a positive or negative result for COVID-19. The testing procedure is simple and fast, swirl the swab in a tube of reagent solution, then remove it. Next, insert a test strip into the solution. After 10 minutes, remove the test strip from the tube to confirm the results.
It is best practice to read the instructions prior to starting the test as it is important to follow the instructions to ensure an accurate result. For a quick overview, watch our test demonstration video above.
Healthcare Provider Instructions for Use (English)
Healthcare Provider Instructions for Use (Spanish)
For any product-related questions, view our FAQs
Meet QVue
Testing without stressing with the QuickVue COVID-19 Test companion app. Make your testing experience easier than ever. Learn more.
Retailers
You are about to leave the QuidelOrtho website for a third-party site. Links which take you outside of the QuidelOrtho website are not under QuidelOrtho’s control, and QuidelOrtho is not responsible for any content or links contained therein. QuidelOrtho is providing these links to you only as a convenience, and such provision does not imply an endorsement by QuidelOrtho of any linked site. Any information you provide to a third-party site will be governed by the third-party’s website Terms of Use, including those related to confidentiality, data privacy and security.
For questions, product updates, news and more, contact us.
Our QuickVue At-Home OTC COVID-19 Test has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) under the new name – QuickVue COVID-19 Test.
The QuickVue COVID-19 Test is a visually read lateral flow immunoassay device intended for the rapid, qualitative detection of SARS-CoV-2 nucleocapsid protein antigens directly in anterior nasal (nares) swab specimens from individuals with signs and symptoms of COVID-19 within the first 5 days from symptom onset. This test is for non-prescription home use by individuals aged 14 years or older testing themselves, or adults testing individuals aged 2 years or older.
The QuickVue COVID-19 Test does not differentiate between SARS-CoV and SARS-CoV-2.
All negative results are presumptive. Symptomatic individuals with an initial negative test result must be re-tested once between 48 and 72 hours after the first test using either an antigen test or a molecular test for SARS-CoV-2. Negative results do not preclude SARS-CoV-2 infections or other pathogens and should not be used as the sole basis for treatment. Positive results do not rule out co-infection with other respiratory pathogens.
This test is not a substitute for visits to a healthcare provider or appropriate follow-up and should not be used to determine any treatments without provider supervision. Individuals who test negative and experience continued or worsening COVID-19 like symptoms, such as fever, cough and/or shortness of breath, should seek follow up care from their healthcare provider.
The performance characteristics for SARS-CoV-2 were established from January 2021 to February 2024 when COVID-19 variants Alpha, Delta, and Omicron were dominant. Test accuracy may change as new SARS-CoV-2 viruses emerge. Additional testing with a lab-based molecular test (e.g., PCR) should be considered in situations where a new virus or variant is suspected.
